{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:09:37Z","timestamp":1794560977172,"version":"4.9.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1136\/annrheumdis-2012-201981","type":"journal-article","created":{"date-parts":[[2012,9,13]],"date-time":"2012-09-13T04:24:40Z","timestamp":1347510280000},"page":"1342-1350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":124,"title":["Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitis"],"prefix":"10.1016","volume":"72","author":[{"given":"Paul A","family":"Monach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roscoe L","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Tomasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Specks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linna","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando C","family":"Fervenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barri J","family":"Fessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary S","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ikl\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cees GM","family":"Kallenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Krischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol A","family":"Langford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E William","family":"St. Clair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Spiera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Tchao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R","family":"Ytterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent J","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A","family":"Merkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/annrheumdis-2012-201981_bib1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/art.1780360312","article-title":"Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis","volume":"36","author":"Kerr","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201981_bib2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0002-9343(99)00064-9","article-title":"Serial measurements of antineutrophil cytoplasmic autoantibodies in patients with systemic vasculitis","volume":"106","author":"Kyndt","year":"1999","journal-title":"Am J Med"},{"key":"10.1136\/annrheumdis-2012-201981_bib3","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O","article-title":"Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study","volume":"43","author":"Boomsma","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201981_bib4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/rheumatology\/40.2.147","article-title":"Are antineutrophil cytoplasmic antibodies a marker predictive of relapse in Wegener's granulomatosis? A prospective study","volume":"40","author":"Girard","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/annrheumdis-2012-201981_bib5","doi-asserted-by":"crossref","first-page":"611","DOI":"10.7326\/0003-4819-147-9-200711060-00005","article-title":"Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis","volume":"147","author":"Finkielman","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1136\/annrheumdis-2012-201981_bib6","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.3899\/jrheum.100302","article-title":"Use of highly sensitive C-reactive protein for followup of Wegener's granulomatosis","volume":"37","author":"Kalsch","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2012-201981_bib7","first-page":"341","article-title":"Objective monitoring of activity in Wegener's granulomatosis by measurement of serum C-reactive protein concentration","volume":"21","author":"Hind","year":"1984","journal-title":"Clin Nephrol"},{"key":"10.1136\/annrheumdis-2012-201981_bib8","first-page":"63","article-title":"Lessons learnt in the management of Wegener's Granulomatosis: long-term follow-up of 60 patients","volume":"45","author":"Sproson","year":"2007","journal-title":"Rhinology"},{"key":"10.1136\/annrheumdis-2012-201981_bib9","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/prca.200600906","article-title":"Screening of serum samples for Wegener's granulomatosis patients using antibody microarrays","volume":"1","author":"Olle","year":"2007","journal-title":"Proteomics Clinical Applications"},{"key":"10.1136\/annrheumdis-2012-201981_bib10","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1365-2249.2005.02770.x","article-title":"Increased expression of chemokines in patients with Wegener's granulomatosis\u2014modulating effects of methylprednisolone in vitro","volume":"140","author":"Torheim","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/annrheumdis-2012-201981_bib11","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1002\/art.27678","article-title":"CCL17\/thymus and activation-related chemokine in Churg-Strauss syndrome","volume":"62","author":"Dallos","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201981_bib12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/09629350400003100","article-title":"Circulating cytokine profile in anti-neutrophilic cytoplasmatic autoantibody-associated vasculitis: prediction of outcome?","volume":"13","author":"Ohlsson","year":"2004","journal-title":"Mediators Inflamm"},{"key":"10.1136\/annrheumdis-2012-201981_bib13","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3899\/jrheum.100735","article-title":"Relationship between markers of platelet activation and inflammation with disease activity in Wegener's granulomatosis","volume":"38","author":"Tomasson","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2012-201981_bib14","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/BF00180543","article-title":"Circulating adhesion molecules ICAM-1, VCAM-1 and E-selectin in systemic vasculitis: marked differences between Wegener's granulomatosis and systemic lupus erythematosus","volume":"72","author":"Mrowka","year":"1994","journal-title":"Clin Investig"},{"key":"10.1136\/annrheumdis-2012-201981_bib15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0385-8146(01)00097-9","article-title":"Serum levels of soluble adhesion molecules ICAM-1, VCAM-1 and E-selectin in patients with Wegener's granulomatosis","volume":"28","author":"Ohta","year":"2001","journal-title":"Auris Nasus Larynx"},{"key":"10.1136\/annrheumdis-2012-201981_bib16","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/ndt\/16.2.276","article-title":"Circulating soluble adhesion molecules in ANCA-associated vasculitis","volume":"16","author":"Ara","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1136\/annrheumdis-2012-201981_bib17","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/art.1780370818","article-title":"Serum levels of soluble adhesion molecules intercellular adhesion molecule 1, vascular cell adhesion molecule 1, and E-selectin in patients with Wegener's granulomatosis. Relationship to disease activity and relevance during followup","volume":"37","author":"Stegeman","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201981_bib18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/ard.58.4.237","article-title":"Monocyte activation in patients with Wegener's granulomatosis","volume":"58","author":"Muller Kobold","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201981_bib19","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/08916930701622783","article-title":"Serum concentration of interleukin-18 is up-regulated in patients with ANCA-associated vasculitis","volume":"40","author":"Hultgren","year":"2007","journal-title":"Autoimmunity"},{"key":"10.1136\/annrheumdis-2012-201981_bib20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s10875-008-9217-0","article-title":"Interleukin-18 binding protein in the sera of patients with Wegener's granulomatosis","volume":"29","author":"Novick","year":"2009","journal-title":"J Clin Immunol"},{"key":"10.1136\/annrheumdis-2012-201981_bib21","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/art.1780350914","article-title":"Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis. Association with disease activity","volume":"35","author":"Schmitt","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201981_bib22","first-page":"666","article-title":"Serum concentrations of neopterin, soluble interleukin 2 receptor, and soluble tumor necrosis factor receptor in Wegener's granulomatosis","volume":"24","author":"Nassonov","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2012-201981_bib23","first-page":"103","article-title":"Lymphocyte activation markers and von Willebrand factor antigen in Wegener's granulomatosis: potential markers for disease activity","volume":"26","author":"D'Cruz","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2012-201981_bib24","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1136\/ard.2005.046219","volume":"65","author":"Sanders","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201981_bib25","first-page":"BR24","article-title":"Soluble cytokine receptors in renal vasculitis and lupus nephritis","volume":"8","author":"Tesar","year":"2002","journal-title":"Med Sci Monit"},{"key":"10.1136\/annrheumdis-2012-201981_bib26","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1136\/ard.2003.017954","article-title":"Expression of matrix metalloproteinases in patients with Wegener's granulomatosis","volume":"63","author":"Bjerkeli","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201981_bib27","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1136\/ard.2004.029033","article-title":"Accelerated atherosclerosis in patients with Wegener's granulomatosis","volume":"64","author":"de Leeuw","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201981_bib28","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1046\/j.1365-2249.2003.02083.x","article-title":"Increased circulating levels of proteinase 3 in patients with anti-neutrophilic cytoplasmic autoantibodies-associated systemic vasculitis in remission","volume":"131","author":"Ohlsson","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/annrheumdis-2012-201981_bib29","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/ard.2009.113621","article-title":"Osteopontin in antineutrophil cytoplasmic autoantibody-associated vasculitis: relation to disease activity, organ manifestation and immunosuppressive therapy","volume":"69","author":"Lorenzen","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201981_bib30","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1034\/j.1600-0463.2001.d01-146.x","article-title":"Tumour necrosis factor-alpha (TNF), lymphotoxin and TNF receptor levels in serum from patients with Wegener's granulomatosis","volume":"109","author":"Jonasdottir","year":"2001","journal-title":"APMIS"},{"issue":"1 Suppl 57","key":"10.1136\/annrheumdis-2012-201981_bib31","first-page":"62","article-title":"Increased levels of BLyS and sVCAM-1 in anti-neutrophil cytoplasmatic antibody (ANCA)-associated vasculitides (AAV)","volume":"28","author":"Schneeweis","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/annrheumdis-2012-201981_bib32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1136\/annrheumdis-2012-201981_bib33","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/1529-0131(200104)44:4<912::AID-ANR148>3.0.CO;2-5","article-title":"A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham vasculitis activity score. International Network for the Study of the Systemic Vasculitides (INSSYS)","volume":"44","author":"Stone","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201981_bib34","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J Royal Stat Soc B"},{"key":"10.1136\/annrheumdis-2012-201981_bib35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","article-title":"The meaning and use of the area under a receiver operating characteristic (ROC) curve","volume":"143","author":"Hanley","year":"1982","journal-title":"Radiology"},{"key":"10.1136\/annrheumdis-2012-201981_bib36","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1148\/radiology.148.3.6878708","article-title":"A method of comparing the areas under receiver operating characteristic curves derived from the same cases","volume":"148","author":"Hanley","year":"1983","journal-title":"Radiology"},{"key":"10.1136\/annrheumdis-2012-201981_bib37","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer"},{"key":"10.1136\/annrheumdis-2012-201981_bib38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4137\/BMI.S7513","article-title":"Building multi-marker algorithms for disease prediction-the role of correlations among markers","volume":"6","author":"Pinsky","year":"2011","journal-title":"Biomark Insights"},{"key":"10.1136\/annrheumdis-2012-201981_bib39","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.joca.2006.04.001","article-title":"Classification of osteoarthritis biomarkers: a proposed approach","volume":"14","author":"Bauer","year":"2006","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1136\/annrheumdis-2012-201981_bib40","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.3899\/jrheum.090346","article-title":"Reappraisal of OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage endpoints in rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: the OMERACT 9 v2 criteria","volume":"36","author":"Maksymowych","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2012-201981_bib41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cccn.2003.12.032","article-title":"Test result variation and the quality of evidence-based clinical guidelines","volume":"346","author":"Fraser","year":"2004","journal-title":"Clin Chim Acta"},{"key":"10.1136\/annrheumdis-2012-201981_bib42","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/sj.bjp.0707441","article-title":"Biomarker method validation in anticancer drug development","volume":"153","author":"Cummings","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1136\/annrheumdis-2012-201981_bib43","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1002\/art.30615","article-title":"Circulating markers of vascular injury and angiogenesis in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"63","author":"Monach","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201981_bib44","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1161\/01.CIR.0000090689.69973.B1","article-title":"Matrix metalloproteinases as novel disease markers in Takayasu arteritis","volume":"108","author":"Matsuyama","year":"2003","journal-title":"Circulation"},{"key":"10.1136\/annrheumdis-2012-201981_bib45","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/ard.61.2.161","article-title":"Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment","volume":"61","author":"Ribbens","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201981_bib46","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.phrs.2011.06.019","article-title":"Serum MMP-8, -9 and TIMP-1 in sepsis: high serum levels of MMP-8 and TIMP-1 are associated with fatal outcome in a multicentre, prospective cohort study. Hypothetical impact of tetracyclines","volume":"64","author":"Lauhio","year":"2011","journal-title":"Pharmacol Res"},{"key":"10.1136\/annrheumdis-2012-201981_bib47","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1034\/j.1600-065X.2003.00073.x","article-title":"The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity","volume":"195","author":"Muller","year":"2003","journal-title":"Immunol Rev"},{"key":"10.1136\/annrheumdis-2012-201981_bib48","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1182\/blood-2008-02-137455","article-title":"Increased serum levels of the chemokine CXCL13 and up-regulation of its gene expression are distinctive features of HCV-related cryoglobulinemia and correlate with active cutaneous vasculitis","volume":"112","author":"Sansonno","year":"2008","journal-title":"Blood"},{"key":"10.1136\/annrheumdis-2012-201981_bib49","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1093\/ndt\/gfp343","article-title":"B-cell-attracting chemokine CXCL13 as a marker of disease activity and renal involvement in systemic lupus erythematosus (SLE)","volume":"24","author":"Schiffer","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1136\/annrheumdis-2012-201981_bib50","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10875-009-9325-5","article-title":"Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity","volume":"30","author":"Wong","year":"2010","journal-title":"J Clin Immunol"},{"key":"10.1136\/annrheumdis-2012-201981_bib51","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1177\/0961203311398513","article-title":"Elevated production of serum B-cell-attracting chemokine-1 (BCA-1\/CXCL13) is correlated with childhood-onset lupus disease activity, severity, and renal involvement","volume":"20","author":"Ezzat","year":"2011","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2012-201981_bib52","first-page":"549","article-title":"Impact of methylprednisolone treatment on the expression of macrophage inflammatory protein 3alpha and B lymphocyte chemoattractant in serum of multiple sclerosis patients","volume":"60","author":"Michalowska-Wender","year":"2008","journal-title":"Pharmacol Rep"},{"key":"10.1136\/annrheumdis-2012-201981_bib53","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1177\/1352458509107017","article-title":"Serum levels of CXCL13 are elevated in active multiple sclerosis","volume":"15","author":"Festa","year":"2009","journal-title":"Mult Scler"},{"key":"10.1136\/annrheumdis-2012-201981_bib54","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1089\/jir.2005.25.702","article-title":"Serum levels of the homeostatic B cell chemokine, CXCL13, are elevated during HIV infection","volume":"25","author":"Widney","year":"2005","journal-title":"J Interferon Cytokine Res"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724213984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724213984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/annrheumdis-2012-201981","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T05:44:53Z","timestamp":1737351893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724213984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":54,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0003496724213984"],"URL":"https:\/\/doi.org\/10.1136\/annrheumdis-2012-201981","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/annrheumdis-2012-201981","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 \u00a9 2013 Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}